Mechanism of Action of Farxiga (Dapagliflozin)
Introduction Dapagliflozin (trade name Farxiga) is a sodium–glucose co‑transporter 2 (SGLT2) inhibitor used in type 2 diabetes mellitus (T2DM) and … Read more
Introduction Dapagliflozin (trade name Farxiga) is a sodium–glucose co‑transporter 2 (SGLT2) inhibitor used in type 2 diabetes mellitus (T2DM) and … Read more
Introduction Finerenone is a nonsteroidal, selective mineralocorticoid receptor antagonist (MRA) approved for reducing the risk of cardiovascular and … Read more